# What's Hot This Year in Infectious Diseases Clinical Science

## TL;DR

This review summarizes key clinical trials and trends in infectious diseases from October 2023 to September 2024, highlighting new antibiotics and prevention methods.

## Contribution

The paper provides a timely summary of recent clinical advancements and outbreaks in infectious diseases in 2024.

## Key findings

- New antibiotics and prevention strategies were tested in multiple clinical trials.
- Outbreaks of dengue, measles, mpox, and avian influenza A underscored the importance of infectious disease research.
- The review highlights updates presented at the IDWeek 2024 session on clinical science in ID.

## Abstract

Clinical science in the field of infectious diseases (ID) moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of ID and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in ID over the past year.

This review covers important public health notices and clinical trials covering a broad range of infectious diseases topics from October 2023 to September 2024. These updates were highlighted in the “What's Hot in ID Clinical Science” session at IDWeek 2024.